Navigation Links
Boston College profs study oxidative stress subcellular to discover its role in diseases

CHESTNUT HILL, MA (9-14-07) Oxidative stress is known to underlie many human diseases including atherosclerosis, Parkinson's disease and Alzheimer's disease. A team of scientists from Boston College has found a means to discover more about what role oxidative stress plays in the development of diseases by studying it at the sub-cellular level.

Available information about the oxidative stress response has come primarily from studies using reactive oxygen species (ROS) with ill-defined locations within the cell, according to the researchers. Thus, they say, existing models do not account for possible differences between stress originating within particular regions of the cell.

Through the use of novel synthetic intracellular targeting molecules that contain oxygen species-generating compounds that cause oxidative stress, the Boston College researchers have targeted specific locations within the cell notably the nucleus and mitochondrion and observed how these molecules interact with nucleic acids (DNA). This will make it easier to determine what parts of a cell are most likely to combat the effects of oxidative stress, and which are weaker, according to the researchers.

That knowledge, in turn, could someday lead to the development of toxic agents that could be used, for example, to attack cancer at the sub-cellular level.

The research, published in the most recent issue of the journal Chemistry & Biology, demonstrates the value of interdepartmental and interdisciplinary collaborations, say the investigators, a trend which is becoming a hallmark of Boston College's natural science programs.

"This experience is an illustration of what can happen when you have an environment where chemists and biologists continually encounter each other, formally and informally. Conversations start, ideas are exchanged and progress is made rapidly; these historically separate disciplines can get together to share observations and work together," said Boston College Professor of Biology Thomas Chiles, a study co-author whose lab was involved in the research.

Chiles says the collaboration began a few years ago when he and Professor Shana Kelley then a faculty member in the Boston College Chemistry Department now at the University of Toronto were serving on a committee together. She described her research to Chiles, and the two scientists began exchanging ideas and sharing lab resources and staff to work on the project.

Kelley had designed highly innovative chemical probes to target specific locations within the cell, Chiles explains. "Once inside, she knew the compounds were killing the cell, but she needed another perspective, because she was dealing with questions of a biological nature. How were these compounds killing the cell" How does a cell survive oxidative stress"

"Past research on oxidative stress focused on the cell as a whole, so it was difficult to ascertain exactly what was happening at the molecular level. But with these compounds developed through Shana's lab, we can begin to understand the specifics of the cell's response to oxidative stress.

"The next step is to look at whether the changes occurring within the cell are its response to the oxidative stress caused by the compounds, or if the compounds themselves are triggering the changes."


Contact: Kathleen Sullivan
Boston College

Related biology news :

1. Boston University biomedical engineers win major grant for pursuit of the $1,000 Genome
2. Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer
3. Researcher at UGA College of Veterinary Medicine identifies new way of combating viral diseases
4. Smooth sailing: cruise ship virus tackled by UH, Baylor College of Medicine
5. Williams College biologist explores photosynthetic apparatus
6. College students who pull all-nighters and get no sleep more likely to have a lower GPA
7. Bioartificial kidney under study at MCG
8. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
9. W.M. Keck Foundation funds study of friendly microbes
10. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
11. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
Post Your Comments:
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... .  A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... The United ... recipient of the 2016 USGA Green Section Award. Presented annually since 1961, the USGA ... his or her work with turfgrass. , Clarke, of Iselin, N.J., is ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
Breaking Biology Technology: